Altimmune's weight-loss drug meets main goal in fatty liver disease trial-March 2024-www.financetom.com

Altimmune's weight-loss drug meets main goal in fatty liver disease trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Altimmune's weight-loss drug meets main goal in fatty liver disease trial

Jun 26, 2025 4:51 AM

June 26 (Reuters) - Altimmune ( ALT ) said on Thursday

its experimental obesity drug met the main goal of a mid-stage

trial studying it as a potential treatment for a fatty liver

disease.

(Reporting by Puyaan Singh in Bengaluru; Editing by Devika

Syamnath)

Previous page： Hilton Prices $1 Billion Debt Offering Next page： Equinix Insider Sold Shares Worth $560,989, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Hilton Prices $1 Billion Debt Offering

Sep 6, 2024

05:39 PM EDT, 09/05/2024 (MT Newswires) -- Hilton Worldwide Holdings ( HLT ) said late Thursday that its indirect subsidiary Hilton Domestic Operating priced a $1 billion offering of 5.875% senior notes due 2033. The company expects the offering to close Monday and plans to use the net proceeds for general corporate purposes. Price: 216.50, Change: +0.50, Percent Change: +0.23...

Equinix Insider Sold Shares Worth $560,989, According to a Recent SEC Filing

Sep 6, 2024

05:38 PM EDT, 09/05/2024 (MT Newswires) -- Scott Crenshaw, Executive Vice President, and General Manager, Digital Services, on September 03, 2024, sold 680 shares in Equinix ( EQIX ) for $560,989. Following the Form 4 filing with the SEC, Crenshaw has control over a total of 1,111 shares of the company, with 1,111 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1101239/000112760224023580/xslF345X05/form4.xml Price:...

FEATURE-US election prompts cities to get a grip on fake news

Sep 6, 2024

* Issue is new focus for local authorities * Pandemic was turning point * U.S. election compelling local action By Carey L. Biron WASHINGTON, Sept 5 (Thomson Reuters Foundation) - R unning U.S. elections has always been a complicated job for local officials, requiring the corralling of hundreds of volunteers, staying on top of ever-changing legal requirements, and now also...

Atlassian Insider Sold Shares Worth $1,296,121, According to a Recent SEC Filing

Sep 6, 2024

05:47 PM EDT, 09/05/2024 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, CEO, Co-Founder, on September 04, 2024, sold 7,948 shares in Atlassian ( TEAM ) for $1,296,121. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 143,064 shares of the company, with 143,064 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024006698/xslF345X05/primarydocument.xml Price: 162.54, Change: +0.64, Percent...